Highly commended - Addressing benzodiazepine and Z-drug prescribing (2024)

Stafford Health and Wellbeing

Project Summary

The original aim of this project was to change the culture of anxiolytic and hypnotic prescribing at our Practice in order to reduce prescribing from the 100th percentile nationally to a level approaching the national median. But this aim was exceeded.

Being such an anomaly for this prescribing metric was cause for concern; the need to prescribe the benzodiazepine and Z-drugs with great care is well documented and the focus of much work for Practice country-wide.

This project began in March 2021, with most patient reviews occurred between April 2021 and April 2022. The challenge was vast. It felt vast. Momentum was built and maintained with a novel use of prescribing data, to set bite-sized goals, understand the clinic-time needed, and monitor progress. An approach which was pharmacist-led, time-resource lean and both evidence-based and patient-centred was developed.

To reduce benzodiazepines and anxiolytics effectively and safely, attention was placed in two areas: consultation skills and prescribing processes.

Key outcomes include: Anxiolytic and hypnotic prescribing fell from the 100th percentile nationally to the 48th percentile in 12 months The number of patients on high dose diazepam and above licensed dose of Z-drugs fell from 80 to 0 The number of patients prescribed benzodiazepine/Z-drugs in combination fell from 54 to 0Other outcomes include significant improvement in the frequency of benzodiazepine/Z-drug medication reviews, patient education on potential harms and sleep hygiene, and the quality of new initiation Z-drug prescribing. Adverse and unintended outcomes were also monitored.

The project is ongoing but now in a ‘maintenance phase’, with less time specifically allocated to it. It is now truly embedded. Overall anxiolytic and hypnotic prescribing has continued to fall to the 30th percentile nationally, reflecting a Practice-wide change in prescribing culture around benzodiazepine and hypnotic prescribing. Thus this project is able to show how a novel use of prescribing data and quality reviews has produced sustainable change.